April 24, 2017 Wilson Therapeutics presented positive final Phase 2 data for WTX101 at EASL Annual Meeting
April 24, 2017 Clinigen and Onxeo initiate Managed Access programme for belinostat in Europe for patients with peripheral T-cell lymphoma (PTCL)
April 20, 2017 GenSight Biologics to Present GS010 at the 2017 Annual Meeting of the American Association of Neurology
April 20, 2017 Targovax initiates first clinical trial with TG02, the second product from its RAS-peptide immunotherapy platform